| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.095 | 0.05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.078 | 0.08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.094 | 0.08 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |